Race Oncology Limited (RAC.AX)
AUD 1.33
(-3.64%)
AUD 1.33
(-3.64%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 4 Million | 3.13 Million | 707.8 Thousand | 387.38 Thousand | 159.37 Thousand | 228.5 Thousand |
| Cost of Revenue | 2.61 Million | 281.19 Thousand | 281.19 Thousand | 281.19 Thousand | 281.19 Thousand | 281.19 Thousand |
| Gross Profit | 1.38 Million | 2.85 Million | 426.61 Thousand | 106.18 Thousand | -121.82 Thousand | -52.69 Thousand |
| Operating Expenses | 14.77 Million | 12.7 Million | 11.2 Million | 6.19 Million | 3.67 Million | 3.48 Million |
| Selling, General and Administrative Expenses | 3.79 Million | 5.11 Million | 5.37 Million | 3.99 Million | 2.4 Million | 2.52 Million |
| Research and Development Expenses | 10.97 Million | 7.59 Million | 5.83 Million | 2.19 Million | 1.27 Million | 956.33 Thousand |
| Other Expenses | - | 3.13 Million | 707.8 Thousand | 424.88 Thousand | 256.44 Thousand | 228.5 Thousand |
| Cost and Expenses | 17.38 Million | 12.98 Million | 11.48 Million | 6.47 Million | 3.96 Million | 3.76 Million |
| Operating Income | -13.38 Million | -12.98 Million | -11.48 Million | -6.47 Million | -3.96 Million | -3.76 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -4 Million | -3.13 Million | -707.8 Thousand | -387.38 Thousand | -159.37 Thousand | -228.5 Thousand |
| Earnings before Tax | -17.82 Million | -13.05 Million | -11.9 Million | -6.72 Million | -4 Million | -3.88 Million |
| Net Income | -13.81 Million | -9.92 Million | -11.2 Million | -6.34 Million | -3.84 Million | -3.65 Million |
| Earnings Per Share Basic | -0.08 | -0.06 | -0.07 | -0.05 | -0.04 | -0.05 |
| Earnings Per Share Diluted | -0.08 | -0.06 | -0.07 | -0.05 | -0.04 | -0.05 |
| Weighted Average Shares Outstanding | 164.5 Million | 160.72 Million | 153.3 Million | 130.96 Million | 106.59 Million | 79.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 164.5 Million | 160.72 Million | 153.3 Million | 130.96 Million | 106.59 Million | 79.84 Million |
| Gross Margin | 0.35 | 0.91 | 0.60 | 0.27 | -0.76 | -0.23 |
| EBIT Margin | -3.55 | -4.05 | -15.83 | -15.99 | -23.09 | -15.24 |
| Profit Margin | -3.45 | -3.17 | -15.83 | -16.37 | -24.13 | -16.01 |
| EBITDA | -14.2 Million | -12.77 Million | -11.62 Million | -6.44 Million | -3.72 Million | -3.6 Million |
| Earnings Before Tax Margin | -3.34 | -4.14 | -16.23 | -16.72 | -24.85 | -16.47 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 4 Million | 3.13 Million | 1.81 Million | 1.32 Million |
| Cost of Revenue | 769.42 Thousand | 281.19 Thousand | 140.59 Thousand | 281.19 Thousand | 140.59 Thousand | 140.59 Thousand |
| Gross Profit | -769.42 Thousand | -281.19 Thousand | 3.86 Million | 2.85 Million | 1.67 Million | 1.18 Million |
| Operating Expenses | 7.19 Million | 17.55 Million | 9.47 Million | 12.7 Million | 7.27 Million | 5.42 Million |
| Selling, General and Administrative Expenses | 2.32 Million | - | 3.36 Million | - | 2.84 Million | 2.26 Million |
| Research and Development Expenses | 4.87 Million | - | 6.1 Million | - | 4.42 Million | 3.16 Million |
| Other Expenses | - | - | - | 3.13 Million | - | - |
| Cost and Expenses | 7.96 Million | 17.83 Million | 9.61 Million | 12.98 Million | 7.41 Million | 5.56 Million |
| Operating Income | -7.96 Million | -17.83 Million | -9.61 Million | -12.98 Million | -7.41 Million | -5.56 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 1.00 | -4 Million | -4 Million | -3.13 Million | -1.81 Million | -1.32 Million |
| Earnings before Tax | -8.15 Million | -17.82 Million | -9.66 Million | -13.05 Million | -7.32 Million | -5.73 Million |
| Net Income | -8.15 Million | -13.81 Million | -5.66 Million | -9.92 Million | -5.51 Million | -4.41 Million |
| Earnings Per Share Basic | -0.05 | - | -0.03 | - | -0.03 | -0.03 |
| Earnings Per Share Diluted | -0.05 | - | -0.03 | - | -0.03 | -0.03 |
| Weighted Average Shares Outstanding | 165.32 Million | 164.5 Million | 163.49 Million | 160.72 Million | 163.06 Million | 161.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 165.32 Million | 164.5 Million | 163.49 Million | 160.72 Million | 163.06 Million | 161.01 Million |
| Gross Margin | - | - | 0.96 | 0.91 | 0.92 | 0.89 |
| EBIT Margin | - | - | -2.37 | - | -4.02 | -4.11 |
| Profit Margin | - | - | -1.41 | -3.17 | -3.04 | -3.34 |
| EBITDA | -8.27 Million | - | -9.47 Million | - | -7.27 Million | -5.42 Million |
| Earnings Before Tax Margin | - | - | -2.40 | -4.14 | -4.09 | -4.21 |
VICO
MND
3386
MFH
XCOP
090350